Why GlycoMimetics Stock Is Trading Higher Monday
Why GlycoMimetics Stock Is Trading Higher Monday
GlycoMimetics, Inc. (NASDAQ:GLYC) stock is moving higher Monday after its chief medical officer disclosed the purchase of company stock.
医疗公司GlycoMimetics, Inc. (NASDAQ:GLYC)股票在周一上涨，因为其首席医学官披露了公司股票的购买情况。
The Details: On Tuesday, the chief medical officer Edwin Rock disclosed in a Form4 that he bought 305,000 shares of the company.
详情：周二，首席医学官埃德温·洛克在Form4中披露，他买入了305,000股该公司的股票。
Rock purchased the shares at an average price of 26 cents.
洛克以平均价格26美分购买了这些股票。
How To Buy GlycoMimetics Stock
如何购买GlycoMimetics股票
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like GlycoMimetics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投资者在决定是否买入股票时，可以做出一些决策。除了估值指标和价格行动，这些可以在Benzinga的报价页面（例如像GlycoMimetics的页面）上找到外，还有像公司是否分红或每个季度买入其大量股票这样的因素。
These are known as capital allocation programs. GlycoMimetics (NASDAQ:GLYC) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
这些被称为资本配置计划。GlycoMimetics (NASDAQ:GLYC)不支付股息，但显然有几种方式可以为股东回报价值。可随时查看Benzinga的股息日历，以确定下一个即将支付股息的公司，以及可以持有公司股票获得多少收益。
For example, if you're looking to earn an annualized return of 21.91%, you'll need to buy a share of Simplify Exchange Traded Funds Simplify Propel Opportunities ETF by the Jun. 25, 2024. Once done, you can expect to receive a nominal payout of $1.25 on Jun. 28, 2024.
例如，如果您想实现年化回报率21.91％，则需要在2024年6月25日前购买Simplify Exchange Traded Funds Simplify Propel Opportunities ETF的一股。完成后，您可以在2024年6月28日收到1.25美元的名义支付。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on GlycoMimetics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
股票回购计划显然是不同的，变量很大。公司可以批准回购计划，并根据授权期间的时间自行购买股票。浏览GlycoMimetics的最新新闻通常会了解到该公司是否最近批准了回购计划。回购计划通常作为股价的支撑，作为需求的后盾。
Related Link: 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
相关链接：本周有重要催化剂的5家生物科技公司：Merck、Intellia、Verona等
GLYC Price Action: At the time of publication, GlycoMimetics shares is trading 20% higher at 32 cents, according to data from Benzinga Pro.
GLYC股票价格行动：根据Benzinga Pro的数据，在发布时，GlycoMimetics股票以32美分的价格上涨了20％。
Image: 8676549 from Pixabay.
图片：来自Pixabay的8676549。